Studies of the coenzyme binding site of rat ovarian 20 alpha-hydroxysteroid dehydrogenase
Abstract:
Rat ovarian 20 alpha-hydroxysteroid dehydrogenase was shown to be effectively inhibited by adenosine derivatives, nicotinamide derivatives, NADP analogs, N-alkylammonium chlorides, and carboxylic acids through coenzyme-competitive inhibition studies. Multiple inhibition analysis was used to demonstrate either simultaneous binding of inhibitors that interact with different regions of the NADP-binding site or mutual exclusion of inhibitors that interact with the same region on the enzyme. The results of these studies demonstrated that the 2'-phosphate, the pyrophosphate, and the positively charged ring nitrogen are important features of the coenzyme structure in binding to the coenzyme-binding site of the enzyme. In addition, the presence of a hydrophobic region near the NADP-binding site was indicated by positive chainlength effects observed in the binding of nicotinamide derivatives, alkylammonium chlorides, and carboxylic acids.
More Related Videos
08:31Anaerobic Protein Purification and Kinetic Analysis via Oxygen Electrode for Studying DesB Dioxygenase Activity and Inhibition
Published on: October 3, 2018
08:00Colorimetric Assessment of Deiodinase 1 Activity in Human Liver Microsomes Using the Sandell-Kolthoff Reaction
Published on: April 10, 2026
Related Concept Videos
Ligand Binding and Linkage
Oxidation of Alkenes: Syn Dihydroxylation with Potassium Permanganate
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
